We have analyzed individual and serial peripheral blood specimens from CML patients harboring single or multiple point mutations in the BCR-ABL1 TKD, and demonstrate that the methods tested show similar results with regard to the assessment of subclone kinetics. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.